Stocks and Investing
Stocks and Investing
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
[ Mon, Aug 05th 2024
] - WOPRAI
Ami Fadia Maintained (BPMC) at Strong Buy with Increased Target to $133 on, Aug 5th, 2024
Ami Fadia of Needham, Maintained "Blueprint Medicines Corporation" (BPMC) at Strong Buy with Increased Target from $130 to $133 on, Aug 5th, 2024.
Ami has made no other calls on BPMC in the last 4 months.
There are 14 other peers that have a rating on BPMC. Out of the 14 peers that are also analyzing BPMC, 4 agree with Ami's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $105 on, Monday, July 29th, 2024
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $115 on, Friday, July 12th, 2024
- Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024
These are the ratings of the 10 analyists that currently disagree with Ami
- Joel Beatty of "Baird" Maintained at Buy with Increased Target to $127 on, Friday, August 2nd, 2024
- Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $138 on, Friday, August 2nd, 2024
- Matthew Biegler of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Monday, July 8th, 2024
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $125 on, Friday, June 7th, 2024
- Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $140 on, Tuesday, May 14th, 2024
- Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
Contributing Sources